Drug Research

The API CDMO market underwent significant changes due to the COVID-19 pandemic. The global rollout of vaccines and therapeutics against the virus led to an unprecedented surge in demand for CDMO (Contract Development and Manufacturing Organization) services. CDMOs played...

The summer of 2023 might become the hottest on record, raising concerns about climate change and the need to prepare for more instances of extreme heat. The occurrence of El Niño, a global weather phenomenon, coupled with high temperatures...

Pharmaceutical companies have collaborated with the WHO through the Sustainable Markets Initiative to implement new supplier requirements, aiming to hasten the healthcare sector's shift to net-zero emissions. The CEOs of AstraZeneca, GSK, Novo Nordisk, Merck, Roche, Sanofi, and Samsung...

The pharmaceutical industry's growing emphasis on sustainability reflects the current trends. Although this sector lags behind others in terms of sustainability advancements, there is significant potential to enhance supply chain sustainability in the future. The global pharmaceutical sector grapples with...

FUJIFILM Diosynth Biotechnologies, a contract development and manufacturing organization (CDMO) for biologics, vaccines, advanced therapies, and oncolytic viruses, disclosed a new strategic business unit (SBU) structure to provide tailored support to large- and small-scale biopharmaceutical customers with high quality...

Charles River Laboratories International, Inc. announced a High Quality (HQ) plasmid manufacturing collaboration with Fondazione Telethon. The rare disease organization will leverage Charles River’s market leading cell and gene contract development and manufacturing organization (CDMO) expertise in High Quality...

Sanyou Biopharmaceuticals and Sinorda Biomedicine entered into a strategic cooperation agreement to advance innovative bispecific antibody drug development. The collaboration will leverage Sanyou's core technology platform for integrated R&D and preclinical development and "super-trillion innovative biologics discovery platform", and Sinorda's...